Trillium Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.9M | Sell |
|
|||||
|
2025
Q1 | $47.7M | Sell |
|
|||||
|
2024
Q4 | $43.8M | Sell |
|
|||||
|
2024
Q3 | $54.7M | Sell |
|
|||||
|
2024
Q2 | $55.6M | Sell |
|
|||||
|
2024
Q1 | $50.1M | Buy |
|
|||||
|
2023
Q4 | $49.4M | Sell |
|
|||||
|
2023
Q3 | $50.9M | Sell |
|
|||||
|
2023
Q2 | $54.1M | Sell |
|
|||||
|
2023
Q1 | $64.2M | Buy |
|
|||||
|
2022
Q4 | $56.9M | Buy |
|
|||||
|
2022
Q3 | $44.9M | Buy |
|
|||||
|
2022
Q2 | $51.5M | Buy |
|
|||||
|
2022
Q1 | $46.7M | Buy |
|
|||||
|
2021
Q4 | $38.5M | Buy |
|
|||||
|
2021
Q3 | $38.1M | Buy |
|
|||||
|
2021
Q2 | $37.1M | Buy |
|
|||||
|
2021
Q1 | $28M | Buy |
|
|||||
|
2020
Q4 | $25.3M | Buy |
|
|||||
|
2020
Q3 | $25.4M | Sell |
|
|||||
|
2020
Q2 | $25.9M | Buy |
|
|||||
|
2020
Q1 | $19.5M | Buy |
|
|||||
|
2019
Q4 | $8.54M | Buy |
|
|||||
|
2019
Q3 | $7.18M | Buy |
|